Lactose (India) Limited

BSE:524202 Stock Report

Market Cap: ₹2.8b

Lactose (India) Past Earnings Performance

Past criteria checks 5/6

Lactose (India) has been growing earnings at an average annual rate of 67.1%, while the Pharmaceuticals industry saw earnings growing at 13.5% annually. Revenues have been growing at an average rate of 29.2% per year. Lactose (India)'s return on equity is 18.1%, and it has net margins of 7.7%.

Key information

67.1%

Earnings growth rate

66.1%

EPS growth rate

Pharmaceuticals Industry Growth17.5%
Revenue growth rate29.2%
Return on equity18.1%
Net Margin7.7%
Next Earnings Update14 Feb 2025

Recent past performance updates

Recent updates

Revenue & Expenses Breakdown

How Lactose (India) makes and spends money. Based on latest reported earnings, on an LTM basis.

Earnings and Revenue History

BSE:524202 Revenue, expenses and earnings (INR Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
30 Sep 241,219931250
30 Jun 241,159811110
31 Mar 241,139681160
31 Dec 231,105531710
30 Sep 23949281580
30 Jun 23836211480
31 Mar 2365812830
31 Dec 22542291340
30 Sep 22493301340
30 Jun 22470321370
31 Mar 22459251380
31 Dec 2141611370
30 Sep 21397-61370
30 Jun 21372-181300
31 Mar 21350-251230
31 Dec 20348-291220
30 Sep 20345-231210
30 Jun 20366-141280
31 Mar 2040011340
31 Dec 19393-11350
30 Sep 1938901320
30 Jun 1939321220
31 Mar 1940671270
31 Dec 18412101270
30 Sep 18408131200
30 Jun 18348-61080
31 Mar 18311-131040
31 Dec 173040920
30 Sep 173198930
30 Jun 1735129970
31 Mar 1735728970
31 Dec 1634015940
30 Sep 163199910
30 Jun 1633622900
31 Mar 1634528820
31 Dec 15339281030
30 Sep 1531825940
30 Jun 152667810
31 Mar 152375670
31 Dec 142422740
30 Sep 142482760
30 Jun 142510610
31 Mar 142220740
31 Dec 132586750

Quality Earnings: 524202 has high quality earnings.

Growing Profit Margin: 524202's current net profit margins (7.7%) are higher than last year (2.9%).

Free Cash Flow vs Earnings Analysis

Past Earnings Growth Analysis

Earnings Trend: 524202's earnings have grown significantly by 67.1% per year over the past 5 years.

Accelerating Growth: 524202's earnings growth over the past year (233.5%) exceeds its 5-year average (67.1% per year).

Earnings vs Industry: 524202 earnings growth over the past year (233.5%) exceeded the Pharmaceuticals industry 20.4%.

Return on Equity

High ROE: 524202's Return on Equity (18.1%) is considered low.

Return on Assets

Return on Capital Employed

Discover strong past performing companies

7D

1Y

7D

1Y

7D

1Y

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/25 23:17
End of Day Share Price 2024/12/24 00:00
Earnings2024/09/30
Annual Earnings2024/03/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Lactose (India) Limited is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution